5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Zika: new trials by email Literature Review of Zika trials Research Report on Zika
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults VLA1601, CpG 1018®, 3M-052-AF - Zika, Zika Virus Infection | Phase 1 | Completed | Valneva Austria GmbH | 150 | 2024-03-25 | 2026-03-09 |
| Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. CHIK low dose, CHIK mid dose, CHIK high dose - Chikungunya, Zika | Phase 1 | Completed | University of Oxford | 120 | 2020-10-23 | 2022-03-23 |
| Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001) ChAdOx1 Zika - Zika | Phase 1 | Completed | University of Oxford | 24 | 2019-10-21 | 2022-05-18 |
| Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study Zika Virus Purified Inactivated Vaccine, Placebo - Zika | Phase 1 | Completed | Kathryn Stephenson | 36 | 2016-12-08 | 2018-08-23 |
| GLS-5700 in Dengue Virus Seropositive Adults GLS-5700, Placebo - Healthy, Zika | Phase 1 | Completed | GeneOne Life Science, Inc. | 160 | 2016-08-01 | 2022-01-20 |
Zika Virus Infection (5) · Chikungunya Fever (1)
Arbovirus Infections (5) · Flaviviridae Infections (5) · Flavivirus Infections (5) · Infections (5) · Mosquito-Borne Diseases (5) · RNA Virus Infections (5) · Vector Borne Diseases (5) · Virus Diseases (5) · Alphavirus Infections (1) · Togaviridae Infections (1)
1018 oligonucleotide (1) · GLS-5700 vaccine (1)
University of Oxford (2) · GeneOne Life Science, Inc. (1) · Kathryn Stephenson (1) · Valneva Austria GmbH (1)
United States (2) · Mexico (1) · Puerto Rico (1) · United Kingdom (1)
Adrian V Hill, DPhill FRCP (1)